Make the most of your genomic screen with our CRISPR and siRNA technologies
Horizon has established a core expertise in functional genomic screening using siRNA and CRISPR-Cas9 screening platforms. Using these screening techniques, we can help you to find and validate novel drug targets, identify mechanisms of drug resistance or sensitivity and to identify synthetic lethality.
If you'd like to discuss your functional genomic screening project with Horizon's team:
As an introduction, we recommend watching our recorded webinar on CRISPR screening: The what, why and how:
The CRISPR-Cas9 Revolution